PeptiSystems appoints Ida Nordberg as CFO
PeptiSystems, a life science company pioneering advanced manufacturing solutions for peptide and oligonucleotide drugs, has appointed Ida Nordberg as Chief Financial Officer (CFO). The appointment marks another step in the company’s development and further strengthens the organization as PeptiSystems enters its next phase of commercialization and international expansion.
UPPSALA, SWEDEN, JUNE 9, 2026 – Ida Nordberg brings more than 15 years of experience in finance roles across the life science industry. Most recently, she served at Oncopeptides and has previously held positions at GE Healthcare and C-RAD. Throughout her career, she has developed broad expertise in financial management, reporting, and business partnering within international operations.
“Over the past year, we have made significant progress in our commercial development and established a foundation for continued growth. Ida Nordberg brings valuable experience from international operations and will be an important asset as we continue to scale the business and build for long-term growth,” says Karin Granath, CEO of PeptiSystems.
“PeptiSystems is at an exciting stage of its journey, with strong commercial momentum. I look forward to joining the team and contributing to the company’s continued growth and further strengthening its position in the market,” says Ida Nordberg.
For more information, please contact:
Karin Granath, CEO
Phone: +46 702-82 07 47
Email: karin.granath@peptisystems.com
About PeptiSystems AB
PeptiSystems is a life science company developing a new generation of flow-through instruments for peptide and oligonucleotide therapeutics synthesis. Utilizing proprietary flow-through column technology, PeptiSystems' instruments significantly reduce production times, enhance synthesis control, and minimize raw material consumption while maintaining high purity and yield. With scalability in mind, these next-generation synthesis instruments seamlessly adapt from small-scale development to large-scale production, enabling pharmaceutical companies and CDMOs to meet the growing global demand for high-performance, cost-effective, and sustainable manufacturing processes. PeptiSystems is headquartered in Uppsala, Sweden. For more information, please visit www.peptisystems.com and follow us on LinkedIn.
Tags:
